Edgewise Therapeutics, Inc.(EWTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EWTX Edgewise Therapeutics, Inc.

Market Closed 10-23 16:00:00 EDT

39.31

-0.68

-1.70%

盘后39.31

+0.000.00%

19:30 EDT

High39.91	Low38.91	Vol911.11K
Open39.91	D1 Closing39.99	Amplitude2.51%
Mkt Cap4.27B	Tradable Cap3.47B	Total Shares108.60M
T/O35.78M	T/O Rate1.03%	Tradable Shares88.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"EWTX","market":"US","secType":"STK","nameCN":"Edgewise Therapeutics, Inc.","latestPrice":39.31,"timestamp":1792785600000,"preClose":39.99,"halted":0,"volume":911110,"hourTrading":{"tag":"盘后","latestPrice":39.31,"preClose":39.31,"latestTime":"19:30 EDT","volume":453905,"amount":17843005.54,"timestamp":1792798203979,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.017004251062765683,"floatShares":88170878,"shares":108604129,"eps":-1.850165,"marketStatus":"Market Closed","change":-0.68,"latestTime":"10-23 16:00:00 EDT","open":39.91,"high":39.91,"low":38.905,"amount":35776175.52602,"amplitude":0.025131,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.850165,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793001600000},"marketStatusCode":7,"adr":0,"listingDate":1616731200000,"exchange":"NASDAQ","adjPreClose":39.99,"preHourTrading":{"tag":"盘前","latestPrice":39.46,"preClose":39.99,"latestTime":"08:50 EDT","volume":349,"amount":14055.340517999999,"timestamp":1792759843564,"change":-0.53,"changeRate":-0.013253,"amplitude":0.064766},"postHourTrading":{"tag":"盘后","latestPrice":39.31,"preClose":39.31,"latestTime":"19:30 EDT","volume":453905,"amount":17843005.54,"timestamp":1792798203979,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5648999069506478,"impliedVol":0.8183,"impliedVolPercentile":0.6892},"requestUrl":"/m/hq/s/EWTX/tweets","defaultTab":"tweets","newsList":[{"id":"2676923514","title":"Edgewise Therapeutics Initiated at Outperform by William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2676923514","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676923514?lang=en_us&edition=fundamental","pubTime":"2026-10-17 04:41","pubTimestamp":1792183260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EWTX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675659971","title":"William Blar Initiates Coverage on Edgewise Therapeutics With Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2675659971","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675659971?lang=en_us&edition=fundamental","pubTime":"2026-10-16 19:27","pubTimestamp":1792150076,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics (EWTX) has an average rating of buy and mean price target of $50.46, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675551835","title":"Edgewise Therapeutics initiated with an Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2675551835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675551835?lang=en_us&edition=fundamental","pubTime":"2026-10-16 08:35","pubTimestamp":1792110919,"startTime":"0","endTime":"0","summary":"William Blair initiated coverage of Edgewise Therapeutics (EWTX) with an Outperform rating. The company’s lead asset EDG-7500 is an oral cardiac sa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-initiated-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/edgewise-therapeutics-initiated-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675346450","title":"Analysts Offer Insights on Healthcare Companies: Edgewise Therapeutics (EWTX), Beam Therapeutics (BEAM) and Madrigal Pharmaceuticals (MDGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2675346450","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675346450?lang=en_us&edition=fundamental","pubTime":"2026-10-14 19:20","pubTimestamp":1791976828,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Edgewise Therapeutics (EWTX), Beam Therapeutics (BEA...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-edgewise-therapeutics-ewtx-beam-therapeutics-beam-and-madrigal-pharmaceuticals-mdgl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-edgewise-therapeutics-ewtx-beam-therapeutics-beam-and-madrigal-pharmaceuticals-mdgl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","HCSG","XBI","XLV","BK4585","BK4137","LU0029874061.USD","BEAM","EWTX","LABU","LU2324357040.USD","LU1861558580.USD","LU1861559042.SGD","BK4556","BK4588","LU0128526141.USD","BK4535","BK4539","BK4007","MDGL","BK4505","BK4139","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675366616","title":"Edgewise’s EQUINOX-HFpEF Trial: A Fresh Catalyst in the Heart Failure Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2675366616","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675366616?lang=en_us&edition=fundamental","pubTime":"2026-10-14 00:30","pubTimestamp":1791909043,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics, Inc. ($EWTX) announced an update on their ongoing clinical study. The EQUINOX-HFpEF study from Edgewise Therapeutics, Inc. t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/edgewises-equinox-hfpef-trial-a-fresh-catalyst-in-the-heart-failure-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/edgewises-equinox-hfpef-trial-a-fresh-catalyst-in-the-heart-failure-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","EWTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673062510","title":"Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Edgewise Therapeutics (EWTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673062510","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673062510?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:20","pubTimestamp":1791472813,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Argenx Se (ARGX) and Edgewise Therapeutics (EWTX) wi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-argenx-se-argx-edgewise-therapeutics-ewtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-argenx-se-argx-edgewise-therapeutics-ewtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235188.USD","XBI","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LABU","BK4539","BK4585","EWTX","IE0009355771.USD","ARGX","LU0889565916.HKD","BK4505","LU0128526141.USD","LU2324357040.USD","LU1983260115.SGD","IE0002141913.USD","BK4581","BK4139","LU0029874061.USD","XLV","BK4007","LU0390134368.USD","HCSG","IE00B4R5TH58.HKD","IBB","FMED","LU0109394709.USD","LU0320765992.SGD","TBXU","LU0823416689.USD","BK4137","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673074732","title":"Edgewise Therapeutics Doses First Patient in Phase 2 EDG-15400 HFpEF Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2673074732","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673074732?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:02","pubTimestamp":1791460957,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics doses first patient in Phase 2 EDG-15400 HFpEF trialEdgewise Therapeutics dosed the first patient in its Phase 2 EQUINOX-HFpEF trial of EDG-15400 for symptomatic HFpEF.The study ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDLbJCynS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EWTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673407446","title":"Edgewise Therapeutics Doses First Patient in Phase 2 Equinox-Hfpef Trial of Edg-15400","url":"https://stock-news.laohu8.com/highlight/detail?id=2673407446","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673407446?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460807,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUAB6XQZ6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","EWTX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672723422","title":"Edgewise Therapeutics (EWTX) Could Be 20% Undervalued After Its EDG 7500 Investor Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672723422","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672723422?lang=en_us&edition=fundamental","pubTime":"2026-10-03 17:24","pubTimestamp":1791019478,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics (EWTX) is holding a special call on September 22, 2026, to walk investors through the differentiated mechanism of action behind its cardiac sarcomere modulator, EDG-7500, for hypertrophic cardiomyopathy.\nRecent trading suggests interest is picking up again in Edgewise Therapeutics, with a 1-day share price return of 2.27% and 7-day share price return of 5.24% ahead of the EDG-7500 call, even though the 30-day share price return declined 1.38%.\nThat short-term momentum...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice2-card/1788952923351"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ewtx/edgewise-therapeutics/news/edgewise-therapeutics-ewtx-could-be-20-undervalued-after-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ewtx/edgewise-therapeutics/news/edgewise-therapeutics-ewtx-could-be-20-undervalued-after-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EWTX","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672274754","title":"Edgewise Therapeutics Grants Inducement Equity Awards Covering 11,251 Shares to Three New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2672274754","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672274754?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:01","pubTimestamp":1790856112,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics grants inducement equity awards covering 11,251 shares to three new employeesEdgewise Therapeutics issued inducement equity awards on Sept. 30, 2026 to three new non-executive em","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL9vBk1p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672754100","title":"Edgewise Therapeutics Reports Inducement Grants as Permitted by the NASDAQ Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754100?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:00","pubTimestamp":1790856006,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA67DKRX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4539","EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670042960","title":"Edgewise Therapeutics Could Benefit From Differentiated EDG-7500 Profile, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2670042960","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670042960?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:42","pubTimestamp":1790358144,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics (EWTX) could benefit from EDG-7500's differentiated drug profile, a potentially lighter phase 3 monitoring approach and possible validation from rival studies, though elevated ta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4007","EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669380384","title":"Edgewise Therapeutics Down over 9%, on Pace for Largest Percent Decrease Since December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2669380384","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669380384?lang=en_us&edition=fundamental","pubTime":"2026-09-24 01:55","pubTimestamp":1790186100,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics, Inc.  is currently at $40.30, down $4.21 or 9.45%--Would be lowest close since Aug. 3, 2026, when it closed at $38.38--On pace for largest percent decrease since Dec. 22, 2025, when it fell 18.04%--Currently down four consecutive days; down 14.14% over this period--Longest losing streak since July 1, 2026, when it fell for five straight trading days--Worst four day stretch since the four days ending July 16, 2026, when it fell 15.9%--Down 3.51% month-to-date; on pace for worst month since July 2026, when it fell 5.41%--Up 62.42% year-to-date--Down 16.64% from its all-time closing high of $48.35 on July 9, 2026--Up 142.95% from 52 weeks ago , when it closed at $16.59--Down 16.64% from its 52-week closing high of $48.35 on July 9, 2026--Up 174.18% from its 52-week closing low of $14.70 on Oct. 14, 2025--Traded as low as $40.01; lowest intraday level since Aug. 3, 2026, when it hit $36.88--Down 10.12% at today's intraday low; largest intraday percent decrease since ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669876844","title":"Edgewise's EDG-7500 Mechanism Lends Confidence, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669876844","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669876844?lang=en_us&edition=fundamental","pubTime":"2026-09-23 23:41","pubTimestamp":1790178065,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics'  EDG-7500 mechanism reveal accounts for strong clinical showing, lending confidence ahead  of phase 3 trial design, RBC said in a Tuesday note.Earlier, the company unveiled a differentiated mechanism of action of its cardiac sarcomere modulator EDG-7500.The mechanism that targets the Regulatory Light Chain has shown in preclinical models to improve cardiac relaxation while preserving systolic function and cardiac reserve, Edgewise said.\"We think the mechanism makes sense of the differentiated clinical profile to date,\" RBC analysts said.\"While the stock is unlikely to move significantly today, we came away confident in EWTX's opportunity to differentiate in HCM from CMIs,\" they added. HCM refers to hypertrophic cardiomyopathy, and CMI to cardiac myosin inhibitors.RBC maintained its outperform rating and $59 price target.Price: 41.26, Change: -3.25, Percent Change: -7.30","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EWTX","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669882494","title":"Edgewise Therapeutics (EWTX) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669882494","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669882494?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:35","pubTimestamp":1790163342,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Leonid Timashev from RBC Capital maintained a Buy rating on Edgewise Therapeutics, with a price target of $59.00. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/edgewise-therapeutics-ewtx-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/edgewise-therapeutics-ewtx-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029864427.USD","LU0310800379.SGD","LU1267930573.SGD","BK4539","EWTX","BK4207","LU0708994859.HKD","LU0128525929.USD","BK4007","GSIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669146649","title":"Edgewise Therapeutics Details Preclinical Profile of EDG-7500 Cardiac Sarcomere Modulator in Hypertrophic Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2669146649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669146649?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:01","pubTimestamp":1790074893,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics details preclinical profile of EDG-7500 cardiac sarcomere modulator in hypertrophic cardiomyopathyEdgewise Therapeutics outlined the preclinical profile for EDG-7500, a first-in-","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL3rsYMz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150816","title":"Edgewise Therapeutics Price Target Raised to $57.00/Share from $45.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150816","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150816?lang=en_us&edition=fundamental","pubTime":"2026-09-21 18:53","pubTimestamp":1789987980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/EWTX/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669155576","title":"US Research Roundup-eBay, Sunbelt Rentals, T-Mobile","url":"https://stock-news.laohu8.com/highlight/detail?id=2669155576","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669155576?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:41","pubTimestamp":1789976490,"startTime":"0","endTime":"0","summary":"US RESEARCH ROUNDUP-eBay, Sunbelt Rentals, T-MobileSept 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several US-listed companies, including eBay, Sunbelt Ren","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDW","LU0251131958.USD","PAA","STBQ","CLIX","LU2322448957.HKD","AMZA","BK4528","BLSM","TMUS","PKB","IHAK","LU0109394709.USD","OKTA","SRRK","ONLN","SPAM","THO","OKTX","AMRZ","IBRN","HUBS","NBIX","GOSS","EMLP","LU1064131342.USD","EWTX","FOUR","HAKY","LU2095319765.USD","BK4504","TTMI","AIRR","AMLP","MTZ","OKTG","TTMX","BKH","PSWD","PAGP","SUNB","MCHB","MLPA","LU1201861249.SGD","BUG","ARHS","IQMX","CL","EBAY","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881914","title":"Edgewise Therapeutics Grants Inducement Equity Awards Covering 31,501 Shares to New Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881914","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881914?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350425,"startTime":"0","endTime":"0","summary":"Edgewise Therapeutics grants inducement equity awards covering 31,501 shares to new hiresEdgewise Therapeutics granted inducement equity awards to four new non-executive employees on Aug. 31, 2026.Sto","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL6yP9rz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EWTX","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664191808","title":"Edgewise Therapeutics Reports Inducement Grants as Permitted by the NASDAQ Listing Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2664191808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664191808?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:00","pubTimestamp":1788350403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA1SNHZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EWTX","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edgewisetx.com","stockEarnings":[{"period":"1week","weight":0.057},{"period":"1month","weight":-0.0424},{"period":"3month","weight":-0.0375},{"period":"6month","weight":0.2448},{"period":"1year","weight":1.6033},{"period":"ytd","weight":0.5841}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0285},{"period":"6month","weight":0.0645},{"period":"1year","weight":0.1313},{"period":"ytd","weight":0.1145}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy. The company also develops EDG-7500, a small molecule for the treatment of hypertrophic cardiomyopathy and other severe cardiac disorders. In addition, it develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. The Company was incorporated in 2017 and is headquartered in Boulder, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.169596},{"month":2,"riseRate":0.2,"avgChangeRate":-0.053086},{"month":3,"riseRate":0.4,"avgChangeRate":-0.097717},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.044897},{"month":5,"riseRate":0.5,"avgChangeRate":-0.020981},{"month":6,"riseRate":0.5,"avgChangeRate":-0.010487},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.007411},{"month":8,"riseRate":0.666667,"avgChangeRate":-0.000236},{"month":9,"riseRate":0.5,"avgChangeRate":0.07779},{"month":10,"riseRate":0.5,"avgChangeRate":0.071729},{"month":11,"riseRate":0.4,"avgChangeRate":0.07088},{"month":12,"riseRate":0.2,"avgChangeRate":0.087485}],"exchange":"NASDAQ","name":"Edgewise Therapeutics, Inc.","nameEN":"Edgewise Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Edgewise Therapeutics, Inc.(EWTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Edgewise Therapeutics, Inc.(EWTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Edgewise Therapeutics, Inc.,EWTX,Edgewise Therapeutics, Inc.股票,Edgewise Therapeutics, Inc.股票老虎,Edgewise Therapeutics, Inc.股票老虎国际,Edgewise Therapeutics, Inc.行情,Edgewise Therapeutics, Inc.股票行情,Edgewise Therapeutics, Inc.股价,Edgewise Therapeutics, Inc.股市,Edgewise Therapeutics, Inc.股票价格,Edgewise Therapeutics, Inc.股票交易,Edgewise Therapeutics, Inc.股票购买,Edgewise Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Edgewise Therapeutics, Inc.(EWTX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Edgewise Therapeutics, Inc.(EWTX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}